LifeStance Health Group, Inc.
Income Statement
| Line Item | Jul 2026 | Jun 2026 | Apr 2026 | Mar 2026 | Feb 2026 | Dec 2025 | Oct 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $435.4M | — | $403.5M | — | — | — | $363.8M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | $108.1M | — | $100.3M | — | — | — | $95.6M |
| Operating Income | — | $30.7M | — | $22.3M | — | — | — | $7.4M |
| Operating Margin | — | 7.0% | — | 5.5% | — | — | — | 2.0% |
| Interest Expense | — | $2.6M | — | $1.8M | — | — | — | $2.8M |
| Pretax Income | — | $27.5M | — | $19.8M | — | — | — | $4.6M |
| Income Tax Expense | — | $3.8M | — | $5.5M | — | — | — | $3.5M |
| Net Income | — | $23.6M | — | $14.2M | — | — | — | $1.1M |
| Net Margin | — | 5.4% | — | 3.5% | — | — | — | 0.3% |
| EPS (Basic) | — | $0.06 | — | $0.04 | — | — | — | $0.00 |
| EPS (Diluted) | — | $0.06 | — | $0.04 | — | — | — | $0.00 |
| Shares Outstanding (Basic) | 382.1M | 383.5M | 387.8M | 387.3M | 389.8M | 388.3M | 389.0M | 387.0M |
| Shares Outstanding (Diluted) | 382.1M | 387.3M | 387.8M | 395.1M | 389.8M | 388.3M | 389.0M | 388.9M |
| Dividends Per Share | — | — | — | — | — | — | — | — |
Obvious prospects for physical growth in a business do not translate into obvious profits for investors.